SG11202111349QA - Recombinant elastin and production thereof - Google Patents

Recombinant elastin and production thereof

Info

Publication number
SG11202111349QA
SG11202111349QA SG11202111349QA SG11202111349QA SG11202111349QA SG 11202111349Q A SG11202111349Q A SG 11202111349QA SG 11202111349Q A SG11202111349Q A SG 11202111349QA SG 11202111349Q A SG11202111349Q A SG 11202111349QA SG 11202111349Q A SG11202111349Q A SG 11202111349QA
Authority
SG
Singapore
Prior art keywords
production
recombinant elastin
elastin
recombinant
Prior art date
Application number
SG11202111349QA
Inventor
Nikolay Ouzounov
Tanya Eliason
Original Assignee
Geltor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltor Inc filed Critical Geltor Inc
Publication of SG11202111349QA publication Critical patent/SG11202111349QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202111349QA 2019-04-12 2020-04-09 Recombinant elastin and production thereof SG11202111349QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962833415P 2019-04-12 2019-04-12
US201962889397P 2019-08-20 2019-08-20
PCT/US2020/027399 WO2020210440A1 (en) 2019-04-12 2020-04-09 Recombinant elastin and production thereof

Publications (1)

Publication Number Publication Date
SG11202111349QA true SG11202111349QA (en) 2021-11-29

Family

ID=72748711

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111349QA SG11202111349QA (en) 2019-04-12 2020-04-09 Recombinant elastin and production thereof

Country Status (12)

Country Link
US (2) US11168126B2 (en)
EP (1) EP3953380A4 (en)
JP (1) JP2022526434A (en)
KR (1) KR20210151930A (en)
CN (1) CN113993885A (en)
AU (1) AU2020270920A1 (en)
CA (1) CA3136691A1 (en)
GB (1) GB2597416A (en)
IL (1) IL287176A (en)
SG (1) SG11202111349QA (en)
TW (1) TW202104254A (en)
WO (1) WO2020210440A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN113993885A (en) 2019-04-12 2022-01-28 格尔托公司 Recombinant elastin and production thereof
WO2022072696A1 (en) * 2020-09-30 2022-04-07 Geltor, Inc. Compositions comprising combinations of collagen or elastin polypeptides with active ingredients and methods of using same
CN113876616A (en) * 2021-10-14 2022-01-04 安徽中美生谷生物科技有限公司 Skin care composition with wrinkle removing effect and preparation method thereof
CN115212131B (en) * 2022-06-16 2023-09-08 广东格烯生物科技股份有限公司 Anti-wrinkle tightening essence containing recombinant elastin and preparation method thereof

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5602183A (en) 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
ATE233813T1 (en) 1991-08-14 2003-03-15 Genentech Inc MODIFIED IMMUNOLOBULINS FOR SPECIFIC FC-EPSILON RECEPTORS
IT1249711B (en) 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
WO1994004690A1 (en) 1992-08-17 1994-03-03 Genentech, Inc. Bispecific immunoadhesins
CA2140933A1 (en) 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
ES2108566T3 (en) 1993-12-10 1997-12-16 Genentech Inc PROCEDURES TO DIAGNOSE ALLERGIES AND TO SELECT ANTI-ALLERGIC THERAPEUTIC AGENTS.
EP0739214B1 (en) 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
CA2181787A1 (en) 1994-03-03 1995-09-08 Claire M. Doerschuk Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
ATE222774T1 (en) 1996-01-23 2002-09-15 Genentech Inc ANTIBODIES TO CD 18 FOR USE AGAINST BRAIN STROKE
AU3056697A (en) 1996-04-12 1997-11-07 Academy Of Finland Synthesis of human procollagens and collagens in recombinant dna systems
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
AU731817C (en) 1996-11-27 2001-11-01 Genentech Inc. Humanized anti-CD11a antibodies
FR2757874B1 (en) 1996-12-17 2003-04-25 Biocem RECOMBINANT COLLAGENS AND DERIVED PROTEINS PRODUCED BY PLANTS, THEIR METHODS OF OBTAINING AND THEIR USES
SI1325932T1 (en) 1997-04-07 2005-08-31 Genentech Inc
EP1860187B1 (en) 1997-05-15 2011-07-13 Genentech, Inc. Apo-2 receptor
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
AUPP472398A0 (en) * 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
WO2000009018A1 (en) 1998-08-10 2000-02-24 Fibrogen, Inc. Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
ES2207340T3 (en) 1998-10-28 2004-05-16 Genentech, Inc. PROCEDURE FOR THE RECOVERY OF HETEROLOGICAL POLYPEPTIDES FROM BACTERIAL CELLS.
US6903244B1 (en) * 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
ES2309012T3 (en) 1999-10-29 2008-12-16 Genentech, Inc. COMPOSITIONS OF THE ANTI-PSCA ANTIBODY AND ITS PROCEDURES AGAINST CANCERIGENE CELLS THAT EXPRESS PSCA.
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
TW499433B (en) 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
CN1177049C (en) 2001-09-12 2004-11-24 上海新世界基因技术开发有限公司 Human protein with function of suppressing cancer cell growth and its coding sequence
SI2289936T1 (en) 2002-12-16 2017-10-30 Genentech, Inc. Immunoglobulin variants and uses thereof
WO2005021772A1 (en) 2003-08-29 2005-03-10 Degussa Ag Process for the preparation of l-lysine
GB0321100D0 (en) 2003-09-09 2003-10-08 Celltech R&D Ltd Biological products
EP1584630A1 (en) 2004-04-08 2005-10-12 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for preparing a modified protein outside a host cell
EP3228711A1 (en) 2004-06-28 2017-10-11 The University Of Western Australia Antisense oligonucleotides for inducing exon skipping and methods of use thereof
EP1856152B1 (en) 2005-02-23 2010-07-07 FUJIFILM Manufacturing Europe B.V. Non-glycosylated recombinant collagen-like polypeptides
EP1889062A4 (en) 2005-06-03 2009-12-23 Texas A & M Univ Sys Specific binding sites in collagen for integrins and use thereof
US7495076B2 (en) 2005-10-13 2009-02-24 Gu Jennifer L Mineral collagen chelates and methods of making and using same
US7279329B2 (en) 2005-10-17 2007-10-09 Industrial Technology Research Institute Expression system for producing collagen
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
JP5275814B2 (en) * 2006-01-17 2013-08-28 フオルスレン，アルネ New surface-exposed Haemophilus influenzae protein (Protein E; pE)
ATE455153T1 (en) 2006-03-13 2010-01-15 Becker & Co Naturinwerk COLLAGEN POWDER AND COLLAGEN-BASED THERMOPLASTIC COMPOSITION FOR PRODUCING MOLDED BODIES
EP1873251A1 (en) * 2006-06-29 2008-01-02 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
US7700126B2 (en) 2006-09-29 2010-04-20 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
CN101311196A (en) 2007-05-24 2008-11-26 昭和高分子株式会社 Method for preparing ethylene-vinyl esters copolymer water-soluble emulsion and ethylene-vinyl ester copolymer water-soluble emulsion
EP2220246B1 (en) 2007-10-26 2015-05-20 Collplant Ltd. Methods of processing recombinant procollagen
US7910134B2 (en) 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
EP2222270B1 (en) 2007-12-26 2018-11-14 Mark A. Pinsky Collagen formulations for improved skin care
US8507652B2 (en) 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
WO2010091251A2 (en) 2009-02-06 2010-08-12 The University Of Medicine And Dentistry Of New Jersey Modular triple-helical collagen-like products
EP2414844B1 (en) * 2009-03-30 2014-12-10 Nordic Bioscience A/S Fibrosis biomarker assay
EP2454367B1 (en) 2009-07-17 2013-10-16 The Texas A&M University System Designer collagens and uses thereof
BR112012000865A2 (en) * 2009-07-17 2019-09-24 T Tabor Aaron "composition and method for cosmetic genetic modification of substantially intact cells"
US9725498B2 (en) 2009-07-17 2017-08-08 The Texas A&M University System Designer collagens and use thereof
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
GB2485385A (en) 2010-11-12 2012-05-16 Univ Manchester Trimeric fusion protein comprising collagen and a prokaryotic/ viral trimerisation domain
DE102010060564A1 (en) 2010-11-15 2012-05-16 Gelita Ag Use of collagen hydrolyzate to improve the health of human skin, hair and / or nails
WO2012149136A1 (en) 2011-04-26 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
CN103842517A (en) 2011-08-03 2014-06-04 莲花组织修复公司 Collagen 7 and related methods
TWI592421B (en) 2011-08-09 2017-07-21 双美生物科技股份有限公司 Triple-crosslinked collagen, method of manufacture and use thereof
RU2014115845A (en) 2011-09-21 2015-10-27 Ливинг Пруф, Инк. COMPOSITIONS AND METHODS FOR TREATING STATES OF DISTURBED BARRIER FUNCTION OF SKIN
JP2013095708A (en) 2011-11-01 2013-05-20 Nicca Chemical Co Ltd Medusa collagen peptide mixture
WO2013065832A1 (en) 2011-11-04 2013-05-10 株式会社ニッピ Dpp-4 inhibitor
JP2014124186A (en) 2012-12-26 2014-07-07 Industrial Technology Research Institute Multivalent antibody fragment and trimer complex thereof
WO2014106830A1 (en) 2013-01-07 2014-07-10 Ramot At Tel-Aviv University Ltd. Jellyfish-derived polymer
EP2976352B1 (en) 2013-03-21 2021-08-18 Evonik Operations GmbH Purification of triple helical proteins
KR101551299B1 (en) 2013-05-23 2015-09-10 아주대학교산학협력단 Neuropilin specific tumor penetrating peptide and fusion protein fused with the same
WO2015012682A2 (en) 2013-07-22 2015-01-29 Universiti Putra Malaysia A method for extracting collagen from aquatic animals, collagen and products containing it
WO2015012683A1 (en) 2013-07-26 2015-01-29 Chan Heng Hui Wood plastering trowel with metal handle
EP3044233A4 (en) 2013-09-09 2017-07-19 Commonwealth Scientific and Industrial Research Organisation Modified bacterial collagen-like proteins
EP3164495B1 (en) 2014-07-03 2024-02-28 Genomatica, Inc. Microorganisms for producing 4c-5c compounds with unsaturation and methods related thereto
KR101721059B1 (en) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 Pharmaceutical composition for preventing or treating ocular surface disease
CN108271391A (en) 2015-08-07 2018-07-10 埃沃尔瓦公司 The generation of steviol glycoside in recombinant host
US10232008B1 (en) 2015-10-05 2019-03-19 Michael P. Moran Multi-purpose nutritional supplement composition
CA3002455C (en) 2015-11-09 2024-02-13 Shiseido Americas Corporation Compositions and methods for application over skin
US9962582B2 (en) 2015-12-24 2018-05-08 Charles T. Antku Golf club crown alignment, aiming and shot shaping aid
US20190002644A1 (en) 2015-12-25 2019-01-03 Spiber Inc. Method for Producing Polymer Aggregate
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
JP6985282B2 (en) 2016-03-16 2021-12-22 フェニックス ティシュー リペア インコーポレイテッドPhoenix Tissue Repair, Inc. Method for purifying type 7 collagen
CA3019373A1 (en) 2016-03-29 2017-10-05 Geltor, Inc. Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1
CN106554410B (en) 2016-06-02 2019-11-26 陕西东大生化科技有限责任公司 A kind of recombination human source collagen and its encoding gene and preparation method
CN106119322B (en) 2016-07-22 2019-10-15 江苏江山聚源生物技术有限公司 A kind of zymotechnique improving recombination human source collagen production level
SG11201901043RA (en) 2016-08-30 2019-03-28 Gelita Ag Use of collagen hydrolysate for improving endurance performance and for stimulating lipid catabolism
FR3058142B1 (en) 2016-10-28 2023-11-24 Gelatines Weishardt COMPOSITION OF COLLAGEN PEPTIDES FROM FISH SKIN AND ITS USE AS MEDICINE
CL2016003387A1 (en) 2016-12-29 2018-10-12 Univ De Santiago De Chile Usach Coating and / or edible film for the preservation of meat products
WO2019023555A1 (en) 2017-07-28 2019-01-31 Evelo Biosciences, Inc. Polymer compositions
WO2019046943A1 (en) 2017-09-06 2019-03-14 University Of Ottawa Collagen-like proteins
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201717134D0 (en) 2017-10-18 2017-12-06 Univ Swansea Monomeric collagen
WO2019099561A1 (en) 2017-11-15 2019-05-23 Geltor, Inc. Textile comprising silanized symbiotic culture of bacteria and yeast
DE102018104590A1 (en) 2018-02-28 2019-08-29 Gelita Ag Nutraceutical or pharmaceutical composition
CA3135835A1 (en) 2019-04-01 2020-10-08 Geltor, Inc. Topical formulations of recombinant collagens
CN113993885A (en) 2019-04-12 2022-01-28 格尔托公司 Recombinant elastin and production thereof

Also Published As

Publication number Publication date
TW202104254A (en) 2021-02-01
US20200325211A1 (en) 2020-10-15
WO2020210440A1 (en) 2020-10-15
US20220127333A1 (en) 2022-04-28
EP3953380A1 (en) 2022-02-16
EP3953380A4 (en) 2023-01-25
JP2022526434A (en) 2022-05-24
AU2020270920A1 (en) 2021-11-04
CA3136691A1 (en) 2020-10-15
GB2597416A (en) 2022-01-26
CN113993885A (en) 2022-01-28
KR20210151930A (en) 2021-12-14
US11168126B2 (en) 2021-11-09
IL287176A (en) 2021-12-01

Similar Documents

Publication Publication Date Title
IL287176A (en) Recombinant elastin and production thereof
IL273620A (en) Recombinant collagen and elastin molecules and uses thereof
GB201819684D0 (en) Production of nitrogen oxides
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
IL287781A (en) Clec12a-binding polypeptides and uses thereof
IL268593A (en) Polypeptide variants and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
GB202007441D0 (en) Polypeptide
GB201917046D0 (en) Improved protein production
EP4048307A4 (en) Recombinant neuraminidase and uses thereof
GB202017649D0 (en) Polypeptide
GB201704071D0 (en) Recombinant mature complement factor 1
IL289122A (en) Polypeptides
EP4072381A4 (en) Headboard
IL292377B1 (en) Superfine compounds and production thereof
EP3377633C0 (en) Recombinant protein production
GB201819200D0 (en) Polypeptide and uses thereof
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
GB202201001D0 (en) Polypeptide and use thereof
SG11202111462VA (en) Asx-specific protein ligases and uses thereof
GB201904720D0 (en) Peptide synthesis and modification
GB202019879D0 (en) Polypeptide
SG11202109015TA (en) Integrated and continuous recombinant protein manufacturing
GB202119034D0 (en) Polypeptide
IL299811A (en) Polypeptide